Autopsy report · NCT00006269
Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer
Cause of deathNo reason given
Life of this trial
- Registered 9 months after it had already started.
- 89 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Novartis
- Sponsor type
- Industry
- Conditions
- Colorectal Cancer; Diarrhea
- Interventions
- irinotecan hydrochloride; octreotide acetate
- Participants
- 89
- Sites
- 2
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.